Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters.
暂无分享,去创建一个
S. Harder | R. Mahnel | U. Klinkhardt | H. Breddin | J. Graff | C. Kirchmaier | D. Westrup | M. Hild